| Lastest Insider Transactions Of Apogee Therapeutics, Inc. ( APGE ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| APGE | Apogee Therapeutics, Inc. | McKenna Mark C. | Directior | 2024-12-12 | Buy | 20,000 | 49.54 | 990,775 | 2024-12-16 06:00:10 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-12-11 | Sell | 4,540 | 48.76 | 221,363 | 2024-12-13 20:01:11 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-12-11 | Option Exercise | 1,815 | 22.86 | 41,491 | 2024-12-13 20:01:11 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-12-04 | Sell | 6,665 | 46.07 | 307,057 | 2024-12-06 20:02:06 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-12-04 | Sell | 15,000 | 46.58 | 698,654 | 2024-12-06 20:01:08 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-11-06 | Sell | 6,665 | 59.12 | 394,041 | 2024-11-08 20:02:19 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-11-06 | Sell | 15,000 | 59.22 | 888,320 | 2024-11-08 20:01:14 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-10-02 | Sell | 6,665 | 56.26 | 374,954 | 2024-10-04 20:02:03 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-10-02 | Sell | 40,000 | 56.23 | 2,249,307 | 2024-10-04 20:01:09 |
| APGE | Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | 2024-08-23 | Sell | 6,000 | 48.26 | 289,560 | 2024-08-23 20:05:04 |
| APGE | Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | 2024-08-23 | Sell | 6,000 | 48.26 | 289,560 | 2024-08-23 20:05:04 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-08-07 | Sell | 7,335 | 40.67 | 298,336 | 2024-08-09 20:05:47 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-08-07 | Sell | 7,335 | 40.67 | 298,336 | 2024-08-09 20:05:47 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-08-07 | Sell | 40,000 | 40.62 | 1,624,764 | 2024-08-09 20:05:12 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-08-07 | Sell | 7,335 | 40.67 | 298,336 | 2024-08-09 20:01:54 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-08-07 | Sell | 7,335 | 40.67 | 298,336 | 2024-08-09 20:01:54 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-07-05 | Sell | 15,000 | 37.26 | 558,900 | 2024-07-05 20:01:58 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-07-03 | Sell | 5,995 | 37.60 | 225,418 | 2024-07-05 20:01:11 |
| APGE | Apogee Therapeutics, Inc. | Shah Nimish P | Directior | 2023-07-13 | Buy | 1,750,000 | 17.00 | 29,750,000 | 2023-07-17 20:00:49 |
| APGE | Apogee Therapeutics, Inc. | Fairmount Funds Management LLC | Directior | 2023-07-13 | Buy | 2,941,176 | 17.00 | 49,999,992 | 2023-07-17 20:00:23 |
